Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer.

Creighton CJ, Chang JC, Rosen JM.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):253-60. doi: 10.1007/s10911-010-9173-1. Epub 2010 Mar 31. Review.

PMID:
20354771
2.

Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.

Blick T, Hugo H, Widodo E, Waltham M, Pinto C, Mani SA, Weinberg RA, Neve RM, Lenburg ME, Thompson EW.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):235-52. doi: 10.1007/s10911-010-9175-z. Epub 2010 Jun 4. Review.

PMID:
20521089
3.

microRNAs and EMT in mammary cells and breast cancer.

Wright JA, Richer JK, Goodall GJ.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):213-23. doi: 10.1007/s10911-010-9183-z. Epub 2010 May 25. Review.

PMID:
20499142
4.

Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions.

Godde NJ, Galea RC, Elsum IA, Humbert PO.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):149-68. doi: 10.1007/s10911-010-9180-2. Epub 2010 May 12. Review.

PMID:
20461450
5.

The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies.

Hollier BG, Evans K, Mani SA.

J Mammary Gland Biol Neoplasia. 2009 Mar;14(1):29-43. doi: 10.1007/s10911-009-9110-3. Epub 2009 Feb 26. Review.

PMID:
19242781
6.

Epithelial-to-mesenchymal transitions and circulating tumor cells.

Bonnomet A, Brysse A, Tachsidis A, Waltham M, Thompson EW, Polette M, Gilles C.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):261-73. doi: 10.1007/s10911-010-9174-0. Epub 2010 May 7. Review.

PMID:
20449641
7.

The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.

Taylor MA, Parvani JG, Schiemann WP.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):169-90. doi: 10.1007/s10911-010-9181-1. Epub 2010 May 15. Review.

8.

Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.

Sabbah M, Emami S, Redeuilh G, Julien S, Prévost G, Zimber A, Ouelaa R, Bracke M, De Wever O, Gespach C.

Drug Resist Updat. 2008 Aug-Oct;11(4-5):123-51. doi: 10.1016/j.drup.2008.07.001. Epub 2008 Aug 20. Review.

PMID:
18718806
9.

Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact.

Foroni C, Broggini M, Generali D, Damia G.

Cancer Treat Rev. 2012 Oct;38(6):689-97. doi: 10.1016/j.ctrv.2011.11.001. Epub 2011 Nov 26. Review.

PMID:
22118888
10.

Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.

Radisky ES, Radisky DC.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):201-12. doi: 10.1007/s10911-010-9177-x. Epub 2010 May 5. Review.

11.

The pathology of EMT in mouse mammary tumorigenesis.

Cardiff RD.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):225-33. doi: 10.1007/s10911-010-9184-y. Epub 2010 Jun 4. Review.

12.

Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.

Micalizzi DS, Farabaugh SM, Ford HL.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):117-34. doi: 10.1007/s10911-010-9178-9. Epub 2010 May 19. Review.

13.

Mammary stem cells and breast cancer--role of Notch signalling.

Farnie G, Clarke RB.

Stem Cell Rev. 2007 Jun;3(2):169-75. Review.

PMID:
17873349
14.

Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells.

Ouyang G, Wang Z, Fang X, Liu J, Yang CJ.

Cell Mol Life Sci. 2010 Aug;67(15):2605-18. doi: 10.1007/s00018-010-0338-2. Epub 2010 Mar 18. Review.

PMID:
20238234
15.

Snail family regulation and epithelial mesenchymal transitions in breast cancer progression.

de Herreros AG, Peiró S, Nassour M, Savagner P.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):135-47. doi: 10.1007/s10911-010-9179-8. Epub 2010 May 9. Review.

16.

Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.

May CD, Sphyris N, Evans KW, Werden SJ, Guo W, Mani SA.

Breast Cancer Res. 2011 Feb 8;13(1):202. doi: 10.1186/bcr2789. Review.

17.

Cancer stem cells and epithelial-mesenchymal transition: revisiting minimal residual disease.

Raimondi C, Gianni W, Cortesi E, Gazzaniga P.

Curr Cancer Drug Targets. 2010 Aug;10(5):496-508. Review.

PMID:
20384575
18.

Stem cells: their role in breast cancer development and resistance to treatment.

Nicolini A, Ferrari P, Fini M, Borsari V, Fallahi P, Antonelli A, Berti P, Carpi A, Miccoli P.

Curr Pharm Biotechnol. 2011 Feb 1;12(2):196-205. Review.

PMID:
21044007
19.

Emerging roles of claudins in human cancer.

Kwon MJ.

Int J Mol Sci. 2013 Sep 4;14(9):18148-80. doi: 10.3390/ijms140918148. Review.

20.

Epithelial plasticity, cancer stem cells and bone metastasis formation.

van der Pluijm G.

Bone. 2011 Jan;48(1):37-43. doi: 10.1016/j.bone.2010.07.023. Epub 2010 Jul 27. Review.

PMID:
20670698
Items per page

Supplemental Content

Write to the Help Desk